Ledger.Open graph →
SEC Form D · filed September 7, 2021

ARS Pharmaceuticals, Inc

Offering
$55.0M
Sold
$55.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Rajeev Dadoo · Conshohocken, PADirectorPeter Kolchinsky · Boston, MADirectorRichard Lowenthal · San Diego, CAExec · DirectorDana Mcgowan · San Diego, CAExecMike Kelly · NEW YORK, NYDirectorBrent Saunders · Morris Plains, NJDirectorPratik Shah · San Francisco, CADirectorJonathan Leff · South San Francisco, CADirectorPhil Schneider · San Diego, CADirectorRajeev Dadoo · Cambridge, MADirectorPeter Kolchinsky · Boston, MADirectorMike Kelly · NEW YORK, NYDirectorBrent Saunders · San Diego, CADirectorRichard Lowenthal · Campbell, CAExec · DirectorDana Mcgowan · San Diego, CAExecPratik Shah · San Diego, CADirectorJonathan Leff · San Francisco, CADirectorPhil Schneider · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗